Page 809 - Williams Hematology ( PDFDrive )

784 Part VI: The Erythrocyte Chapter 49: Disorders of Hemoglobin Structure: Sickle Cell Anemia and Related Abnormalities 785

109. Mohandas N, Johnson A, Wyatt J, et al: Automated quantitation of cell density distribu- 146. Platt OS, Thorington BD, Brambilla DJ, et al: Pain in sickle cell disease. Rates and risk
tion and hyperdense cell fraction in RBC disorders. Blood 74(1):442–447, 1989. factors. N Engl J Med 325(1):11–16, 1991.
110. Sherwood JB, Goldwasser E, Chilcote R, et al: Sickle cell anemia patients have low ery- 147. Vichinsky EP, Johnson R, Lubin BH: Multidisciplinary approach to pain management
thropoietin levels for their degree of anemia. Blood 67(1):46–49, 1986. in sickle cell disease. Am J Pediatr Hematol Oncol 4(3):328–333, 1982.
111. Boggs DR, Hyde F, Srodes C: An unusual pattern of neutrophil kinetics in sickle cell 148. Styles LA, Vichinsky E: Effects of a long-term transfusion regimen on sickle cell-related
anemia. Blood 41(1):59–65, 1973. illnesses. J Pediatr 125(6 Pt 1):909–911, 1994.
112. Buchanan GR, Glader BE: Leukocyte counts in children with sickle cell disease. Com- 149. Dampier CD, Smith WR, Wager CG, et al: IMPROVE trial: A randomized controlled
parative values in the steady state, vaso-occlusive crisis, and bacterial infection. Am J trial of patient-controlled analgesia for sickle cell painful episodes: Rationale, design
Dis Child 132(4):396–398, 1978. challenges, initial experience, and recommendations for future studies. Clin Trials
113. Corvelli AI, Binder RA, Kales A: Disseminated intravascular coagulation in sickle cell 10(2):319–331, 2013.
crisis. South Med J 72(4):505–506, 1979. 150. Gladwin MT, Kato GJ, Weiner D, et al: Nitric oxide for inhalation in the acute treat-
114. Karayalcin G, Lanzkowsky P, Kazi AB: Zinc deficiency in children with sickle cell dis- ment of sickle cell pain crisis: A randomized controlled trial. JAMA 305(9):893–902,
ease. Am J Pediatr Hematol Oncol 1(3):283–284, 1979. 2011.
115. Natta C, Machlin L: Plasma levels of tocopherol in sickle cell anemia subjects. Am J Clin 151. Gladwin MT, Vichinsky E: Pulmonary complications of sickle cell disease. N Engl J Med
Nutr 32(7):1359–1362, 1979. 359(21):2254–2265, 2008.
116. Niell HB, Leach BE, Kraus AP: Zinc metabolism in sickle cell anemia. JAMA 152. Vichinsky EP, Neumayr LD, Earles AN, et al: Causes and outcomes of the acute chest
242(24):2686–2687, 1979. syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J
117. Mario N, Baudin B, Aussel C, et al: Capillary isoelectric focusing and high-performance Med 342(25):1855–1865, 2000.
cation-exchange chromatography compared for qualitative and quantitative analysis of 153. Miller ST: How I treat acute chest syndrome in children with sickle cell disease. Blood
hemoglobin variants. Clin Chem 43(11):2137–2142, 1997. 117(20):5297–5305, 2011.
118. Partington MD, Aronyk KE, Byrd SE: Sickle cell trait and stroke in children. Pediatr 154. Vichinsky EP, Neumayr LD, Gold JI, et al: Neuropsychological dysfunction and neu-
Neurosurg 20(2):148–151, 1994. roimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA
119. Steinberg MH: DNA diagnosis for the detection of sickle hemoglobinopathies. Am J 303(18):1823–1831, 2010.
Hematol 43(2):110–115, 1993. 155. Emre U, Miller ST, Gutierez M, et al: Effect of transfusion in acute chest syndrome of
120. Hamideh D, Alvarez O: Sickle cell disease related mortality in the United States sickle cell disease. J Pediatr 127(6):901–904, 1995.
(1999–2009). Pediatr Blood Cancer 60(9):1482–1486, 2013. 156. Emre U, Miller ST, Rao SP, et al: Alveolar-arterial oxygen gradient in acute chest syn-
121. Platt OS, Brambilla DJ, Rosse WF, et al: Mortality in sickle cell disease. Life expectancy drome of sickle cell disease. J Pediatr 123(2):272–275, 1993.
and risk factors for early death. N Engl J Med 330(23):1639–1644, 1994. 157. Bellet PS, Kalinyak KA, Shukla R, et al: Incentive spirometry to prevent acute pulmo-
122. Serjeant GR, Serjeant BE, Mason KP, et al: The changing face of homozygous sickle cell nary complications in sickle cell diseases. N Engl J Med 333(11):699–703, 1995.
disease: 102 patients over 60 years. Int J Lab Hematol 31(6):585–596, 2009. 158. Uchida K, Rackoff WR, Ohene-Frempong K, et al: Effect of erythrocytapheresis on
123. National Heart, Lung, and Blood Institute: The Management of Sickle Cell Disease, ed 4, arterial oxygen saturation and hemoglobin oxygen affinity in patients with sickle cell
pp 59–74. NIH Publication No. 02–2117. National Institutes of Health, Bethesda, MD, disease. Am J Hematol 59(1):5–8, 1998.
2002. 159. Bernini JC, Rogers ZR, Sandler ES, et al: Beneficial effect of intravenous dexamethasone
124. Yale SH, Nagib N, Guthrie T: Approach to the vaso-occlusive crisis in adults with sickle in children with mild to moderately severe acute chest syndrome complicating sickle
cell disease. Am Fam Physician 61(5):1349–1356, 1363–1364, 2000. cell disease. Blood 92(9):3082–3089, 1998.
125. Ballas SK, Gupta K, Adams-Graves P: Sickle cell pain: A critical reappraisal. Blood 160. Charache S, Terrin ML, Moore RD, et al: Effect of hydroxyurea on the frequency of pain-
120(18):3647–3656, 2012. ful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in
126. Ballas SK, Kesen MR, Goldberg MF, et al: Beyond the definitions of the phenotypic Sickle Cell Anemia. N Engl J Med 332(20):1317–1322, 1995.
complications of sickle cell disease: An update on management. ScientificWorldJournal 161. Wang WC, Ware RE, Miller ST, et al: Hydroxycarbamide in very young children with
2012:949535, 2012. sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet
127. Kinney TR, Ware RE, Schultz WH, et al: Long-term management of splenic sequestra- 377(9778):1663–1672, 2011.
tion in children with sickle cell disease. J Pediatr 117(2 Pt 1):194–199, 1990. 162. Klings ES, Machado RF, Barst RJ, et al: An official American Thoracic Society clinical
128. Solanki DL, Kletter GG, Castro O: Acute splenic sequestration crises in adults with practice guideline: Diagnosis, risk stratification, and management of pulmonary hyper-
sickle cell disease. Am J Med 80(5):985–990, 1986. tension of sickle cell disease. Am J Respir Crit Care Med 189(6):727–740, 2014.
129. Bowcock SJ, Nwabueze ED, Cook AE, et al: Fatal splenic sequestration in adult sickle 163. Morris CR: Asthma management: Reinventing the wheel in sickle cell disease. Am J
cell disease. Clin Lab Haematol 10(1):95–99, 1988. Hematol 84(4):234–241, 2009.
130. Koduri PR, Agbemadzo B, Nathan S: Hemoglobin S-C disease revisited: Clinical study 164. Klings ES, Wyszynski DF, Nolan VG, et al: Abnormal pulmonary function in adults
of 106 adults. Am J Hematol 68(4):298–300, 2001. with sickle cell anemia. Am J Respir Crit Care Med 173(11):1264–1269, 2006.
131. Vichinsky E, Lubin BH: Suggested guidelines for the treatment of children with sickle 165. Newaskar M, Hardy KA, Morris CR: Asthma in sickle cell disease. ScientificWorldJour-
cell anemia. Hematol Oncol Clin North Am 1(3):483–501, 1987. nal 11:1138–1152, 2011.
132. de Montalembert M, Dumont MD, Heilbronner C, et al: Delayed hemolytic transfusion 166. Varat MA, Adolph RJ, Fowler NO: Cardiovascular effects of anemia. Am Heart J
reaction in children with sickle cell disease. Haematologica 96(6):801–807, 2011. 83(3):415–426, 1972.
133. Solomon LR: Treatment and prevention of pain due to vaso-occlusive crises in adults 167. Balfour IC, Covitz W, Davis H, et al: Cardiac size and function in children with sickle
with sickle cell disease: An educational void. Blood 111(3):997–1003, 2008. cell anemia. Am Heart J 108(2):345–350, 1984.
134. Labbe E, Herbert D, Haynes J: Physicians’ attitude and practices in sickle cell disease 168. Fitzhugh CD, Lauder N, Jonassaint JC, et al: Cardiopulmonary complications leading to
pain management. J Palliat Care 21(4):246–251, 2005. premature deaths in adult patients with sickle cell disease. Am J Hematol 85(1):36–40,
135. Elander J, Lusher J, Bevan D, et al: Understanding the causes of problematic pain man- 2010.
agement in sickle cell disease: Evidence that pseudoaddiction plays a more important 169. Manci EA, Culberson DE, Yang YM, et al: Causes of death in sickle cell disease: An
role than genuine analgesic dependence. J Pain Symptom Manage 27(2):156–169, 2004. autopsy study. Br J Haematol 123(2):359–365, 2003.
136. Ballas SK: Ethical issues in the management of sickle cell pain. Am J Hematol 68(2):127– 170. Darbari DS, Kple-Faget P, Kwagyan J, et al: Circumstances of death in adult sickle cell
132, 2001. disease patients. Am J Hematol 81(11):858–863, 2006.
137. Aisiku IP, Smith WR, McClish DK, et al: Comparisons of high versus low emergency 171. Chacko P, Kraut EH, Zweier J, et al: Myocardial infarction in sickle cell disease: Use of
department utilizers in sickle cell disease. Ann Emerg Med 53(5):587–593, 2009. translational imaging to diagnose an under-recognized problem. J Cardiovasc Transl
138. McClish DK, Smith WR, Dahman BA, et al: Pain site frequency and location in sickle Res 6(5):752–761, 2013.
cell disease: The PiSCES project. Pain 145(1–2):246–251, 2009. 172. Voskaridou E, Christoulas D, Terpos E: Sickle-cell disease and the heart: Review of the
139. Dampier C, Ely E, Brodecki D, et al: Home management of pain in sickle cell disease: A current literature. Br J Haematol 157(6):664–673, 2012.
daily diary study in children and adolescents. J Pediatr Hematol Oncol 24(8):643–647, 173. Pegelow CH, Colangelo L, Steinberg M, et al: Natural history of blood pressure in sickle
2002. cell disease: Risks for stroke and death associated with relative hypertension in sickle
140. Rees DC, Olujohungbe AD, Parker NE, et al: Guidelines for the management of the cell anemia. Am J Med 102(2):171–177, 1997.
acute painful crisis in sickle cell disease. Br J Haematol 120(5):744–752, 2003. 174. Stockman JA, Nigro MA, Mishkin MM, et al: Occlusion of large cerebral vessels in
141. Benjamin L, Dampier CD, Jacox, A, et al: Guideline for Management of Acute Pain in sickle-cell anemia. N Engl J Med 287(17):846–849, 1972.
Sickle-Cel Disease. Glenview, IL, 2001. 175. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al: Cerebrovascular accidents in sickle
142. Ballas SK: Meperidine for acute sickle cell pain in the emergency department: Revisited cell disease: Rates and risk factors. Blood 91(1):288–294, 1998.
controversy. Ann Emerg Med 51(2):217, 2008. 176. Steen RG, Xiong X, Langston JW, et al: Brain injury in children with sickle cell disease:
143. Howland MA, Goldfrank LR: Why meperidine should not make a comeback in treating Prevalence and etiology. Ann Neurol 54(5):564–572, 2003.
patients with sickle cell disease. Ann Emerg Med 51(2):203–205, 2008. 177. Webb J, Kwiatkowski J: L. Stroke in patients with sickle cell disease. Expert Rev Hematol
144. Morgan MT: Use of meperidine as the analgesic of choice in treating pain from acute 6(3):301–315, 2013.
painful sickle cell crisis. Ann Emerg Med 51(2):202–203, 2008. 178. Bernaudin F, Verlhac S, Arnaud C, et al: Impact of early transcranial Doppler screening
145. Benjamin LJ, Swinson GI, Nagel RL: Sickle cell anemia day hospital: An approach for and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell ane-
the management of uncomplicated painful crises. Blood 95(4):1130–1136, 2000. mia cohort. Blood 117(4):1130–1140; quiz 1436, 2011.

Kaushansky_chapter 49_p0759-0788.indd 784 9/18/15 3:02 PM